CO6361957A2 - Nuevos compuestos heterociclicos nitrogenados, preparacion de los mismos y utilizacion de los mismos como medicamentos antibacterianos - Google Patents
Nuevos compuestos heterociclicos nitrogenados, preparacion de los mismos y utilizacion de los mismos como medicamentos antibacterianosInfo
- Publication number
- CO6361957A2 CO6361957A2 CO11040684A CO11040684A CO6361957A2 CO 6361957 A2 CO6361957 A2 CO 6361957A2 CO 11040684 A CO11040684 A CO 11040684A CO 11040684 A CO11040684 A CO 11040684A CO 6361957 A2 CO6361957 A2 CO 6361957A2
- Authority
- CO
- Colombia
- Prior art keywords
- same
- nitrogen
- amino
- group
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invención se refiere a compuestos heterocíclicos nitrogenados de fórmula general (I) en la cual:R1 representa un radical (CH2)n-NH2, siendo o igual a 1 o 2;R2 representa un átomo de hidrógeno;R1 y R4 forman juntos un heterociclo nitrogenado de carácter aromático de 5 vértices que contiene 1, 2 o 3 átomos de nitrógeno, sustituido en este átomo de nitrógeno oen uno de estos átomos de nitrógeno por un grupo (CH2)m- (C(O))p-R5, siendo m igual a 0, 1, 2 o 3, siendo p igual a 0 o 1 y R5 representa un grupo hidroxi, en cuyo caso p es iguala 1, o un grupo amino, alquiIo(C1-C6) o dialquilo(C1-C6) amino, o un heterociclo nitrogenado de carácter aromático de 5 o 6 vértices que contiene 1 o 2 átomos de nitrógeno y, eventualmente, 1 átomo de oxígeno o de azufre;siendo evidente que, cuando el sub-grupo (C(O))p-R5 forma un grupo carboxi, amino, alquilo(C1-C6) o dialquilo(C1-C6) amino, m es diferente de 0 o 1;en forma libre y en forma de zwitteriones y de sales con bases y ácidos minerales u orgánicos farmacéuticamente aceptables, a la preparación y utilización de los mismos como medicamentos antibacterianos
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0805472A FR2936798B1 (fr) | 2008-10-03 | 2008-10-03 | Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens. |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6361957A2 true CO6361957A2 (es) | 2012-01-20 |
Family
ID=40548019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO11040684A CO6361957A2 (es) | 2008-10-03 | 2011-04-01 | Nuevos compuestos heterociclicos nitrogenados, preparacion de los mismos y utilizacion de los mismos como medicamentos antibacterianos |
Country Status (18)
Country | Link |
---|---|
US (1) | US8067435B2 (es) |
EP (2) | EP2344499A1 (es) |
JP (1) | JP5555240B2 (es) |
KR (1) | KR20110067137A (es) |
CN (1) | CN102203094B (es) |
AU (1) | AU2009299511A1 (es) |
BR (1) | BRPI0919810A8 (es) |
CA (1) | CA2739503A1 (es) |
CL (1) | CL2011000729A1 (es) |
CO (1) | CO6361957A2 (es) |
EA (1) | EA021799B1 (es) |
EC (1) | ECSP11010946A (es) |
FR (1) | FR2936798B1 (es) |
IL (1) | IL212059A0 (es) |
MX (1) | MX2011003573A (es) |
PE (1) | PE20110845A1 (es) |
WO (1) | WO2010038115A1 (es) |
ZA (1) | ZA201102429B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8772490B2 (en) | 2010-12-22 | 2014-07-08 | Meiji Seika Pharma Co., Ltd. | Optically active diazabicyclooctane derivatives and process for preparing the same |
US9006230B2 (en) * | 2011-08-30 | 2015-04-14 | Wockhardt Ltd. | 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections |
BR112014003476A2 (pt) * | 2011-09-13 | 2017-03-01 | Wockhardt Ltd | compostos contendo nitrogênio e seu uso |
US8927724B2 (en) * | 2012-03-30 | 2015-01-06 | Cubist Pharmaceuticals, Inc. | Isoxazole beta-lactamase inhibitors |
AR090539A1 (es) * | 2012-04-02 | 2014-11-19 | Astrazeneca Ab | COMPUESTOS INHIBIDORES DE b LACTAMASA |
HUE046893T2 (hu) | 2012-05-30 | 2020-04-28 | Meiji Seika Pharma Co Ltd | Új ß-laktamáz inhibitor és eljárás elõállítására |
BR112015003592B1 (pt) * | 2012-08-25 | 2020-04-14 | Wockhardt Ltd | derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e seu uso no tratamento de infecções bacterianas |
KR102239725B1 (ko) | 2013-09-24 | 2021-04-12 | 메이지 세이카 파루마 가부시키가이샤 | 디아자비시클로옥탄 유도체의 제조법과 그의 중간체 |
EP3299370B1 (en) | 2013-10-08 | 2021-11-24 | Meiji Seika Pharma Co., Ltd. | Crystalline forms of diazabicyclooctane derivative and production process thereof |
IN2013MU03216A (es) * | 2013-10-11 | 2015-07-03 | Wockhardt Ltd | |
EA033829B1 (ru) | 2014-11-17 | 2019-11-29 | Entasis Therapeutics Ltd | Комбинированная терапия для лечения устойчивых бактериальных инфекций |
ES2821826T3 (es) | 2014-12-05 | 2021-04-27 | Meiji Seika Pharma Co Ltd | Método para producir cristales de derivado de diazabiciclooctano y preparación liofilizada estable |
EP3075733A1 (en) * | 2015-03-31 | 2016-10-05 | Mutabilis | Novel heterocyclic compounds and their use in preventing or treating bacterial infections |
US10072006B2 (en) * | 2015-03-31 | 2018-09-11 | Mutabilis | Heterocyclic compounds and their use in preventing or treating bacterial infections |
EP3277277B1 (en) * | 2015-04-03 | 2021-01-06 | Mutabilis | Heterocyclic compounds and their use in preventing or treating bacterial infections |
BR112018006422A2 (pt) | 2015-10-02 | 2018-10-09 | Legochem Biosciences Inc | composições e métodos para inibir beta-lactamase |
ES2927986T3 (es) | 2016-09-16 | 2022-11-14 | Entasis Therapeutics Ltd | Compuestos inhibidores de las betalactamasas |
HUE057592T2 (hu) | 2017-05-08 | 2022-05-28 | Entasis Therapeutics Inc | Vegyületek és eljárások bakteriális fertõzések kezelésére |
EP3604315A1 (en) | 2018-07-30 | 2020-02-05 | Mutabilis | Heterocyclic compounds and their use in preventing or treating bacterial infections |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6387928B1 (en) * | 1997-09-15 | 2002-05-14 | The Procter & Gamble Co. | Antimicrobial quinolones, their compositions and uses |
DK1015445T3 (da) * | 1997-09-15 | 2009-05-11 | Procter & Gamble | Antimikrobielle quinoloner, deres sammensætninger og anvendelser |
FR2812635B1 (fr) | 2000-08-01 | 2002-10-11 | Aventis Pharma Sa | Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens |
IL155679A0 (en) * | 2000-12-14 | 2003-11-23 | Procter & Gamble | Antimicrobial quinolones |
AU2002230893B2 (en) * | 2000-12-14 | 2005-06-09 | The Procter & Gamble Company | Antimicrobial 2-pyridones, their compositions and uses |
FR2825705B1 (fr) * | 2001-06-08 | 2005-05-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
FR2833596B1 (fr) * | 2001-12-14 | 2005-02-18 | Aventis Pharma Sa | Procede de preparation de derives d'echinocandine |
FR2835186B1 (fr) * | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases |
US6900224B2 (en) * | 2002-07-31 | 2005-05-31 | The Procter & Gamble Company | Antimicrobial quinolones, their compositions and uses |
FR2844273B1 (fr) | 2002-09-05 | 2008-04-04 | Aventis Pharma Sa | Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens. |
FR2844270B1 (fr) * | 2002-09-11 | 2006-05-19 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent |
FR2844268B1 (fr) * | 2002-09-11 | 2004-10-22 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent |
FR2848210B1 (fr) * | 2002-12-06 | 2007-10-19 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases |
US7439253B2 (en) * | 2002-12-06 | 2008-10-21 | Novexel | Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors |
US7232833B2 (en) * | 2003-03-28 | 2007-06-19 | Novexel | 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them |
US7449481B2 (en) * | 2004-04-13 | 2008-11-11 | Cephalon, Inc. | Thio-substituted biaryl-methanesulfinyl derivatives |
FR2914923B1 (fr) * | 2007-04-12 | 2013-06-14 | Novexel | Nouveaux composes heterocycliques azotes,leur preparation et leur utilisation comme medicaments antibacteriens. |
FR2937034B1 (fr) * | 2008-10-10 | 2012-11-23 | Novexel | Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens |
-
2008
- 2008-10-03 FR FR0805472A patent/FR2936798B1/fr not_active Expired - Fee Related
-
2009
- 2009-08-03 EP EP09786093A patent/EP2344499A1/fr not_active Withdrawn
- 2009-08-03 KR KR1020117009615A patent/KR20110067137A/ko not_active Application Discontinuation
- 2009-08-03 MX MX2011003573A patent/MX2011003573A/es active IP Right Grant
- 2009-08-03 CN CN200980141781.3A patent/CN102203094B/zh not_active Expired - Fee Related
- 2009-08-03 PE PE2011000827A patent/PE20110845A1/es not_active Application Discontinuation
- 2009-08-03 WO PCT/IB2009/006433 patent/WO2010038115A1/fr active Application Filing
- 2009-08-03 BR BRPI0919810A patent/BRPI0919810A8/pt not_active IP Right Cessation
- 2009-08-03 AU AU2009299511A patent/AU2009299511A1/en not_active Abandoned
- 2009-08-03 EP EP14188601.0A patent/EP2845855A1/fr not_active Withdrawn
- 2009-08-03 CA CA2739503A patent/CA2739503A1/fr not_active Abandoned
- 2009-08-03 JP JP2011529643A patent/JP5555240B2/ja not_active Expired - Fee Related
- 2009-08-03 EA EA201170522A patent/EA021799B1/ru not_active IP Right Cessation
- 2009-08-05 US US12/536,096 patent/US8067435B2/en not_active Expired - Fee Related
-
2011
- 2011-03-30 ZA ZA2011/02429A patent/ZA201102429B/en unknown
- 2011-03-31 IL IL212059A patent/IL212059A0/en unknown
- 2011-04-01 CL CL2011000729A patent/CL2011000729A1/es unknown
- 2011-04-01 CO CO11040684A patent/CO6361957A2/es active IP Right Grant
- 2011-04-01 EC EC2011010946A patent/ECSP11010946A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN102203094A (zh) | 2011-09-28 |
IL212059A0 (en) | 2011-06-30 |
CN102203094B (zh) | 2014-04-02 |
EA201170522A1 (ru) | 2011-12-30 |
BRPI0919810A2 (pt) | 2017-10-31 |
US8067435B2 (en) | 2011-11-29 |
ECSP11010946A (es) | 2011-05-31 |
EP2344499A1 (fr) | 2011-07-20 |
CA2739503A1 (fr) | 2010-04-08 |
EA021799B1 (ru) | 2015-09-30 |
PE20110845A1 (es) | 2011-11-17 |
JP5555240B2 (ja) | 2014-07-23 |
KR20110067137A (ko) | 2011-06-21 |
FR2936798B1 (fr) | 2012-09-28 |
BRPI0919810A8 (pt) | 2017-12-12 |
MX2011003573A (es) | 2011-08-12 |
EP2845855A1 (fr) | 2015-03-11 |
WO2010038115A1 (fr) | 2010-04-08 |
US20100087648A1 (en) | 2010-04-08 |
FR2936798A1 (fr) | 2010-04-09 |
CL2011000729A1 (es) | 2012-07-06 |
AU2009299511A1 (en) | 2010-04-08 |
ZA201102429B (en) | 2012-05-30 |
JP2012504593A (ja) | 2012-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6361957A2 (es) | Nuevos compuestos heterociclicos nitrogenados, preparacion de los mismos y utilizacion de los mismos como medicamentos antibacterianos | |
CO6640247A2 (es) | Compuesto[5.6]heterociclico o una sal farmacológicamente aceptable del mismo útil para la prevención de enfermedades asociadas con el metabolismo óseo | |
ECSP099682A (es) | Nuevos compuestos heterociclicos nitrogenados, su preparación y su utilización como medicamentos antibacterianos | |
AR119698A2 (es) | Compuesto amida n-urea sustituida derivado de aminoácido | |
DOP2011000254A (es) | Compuestos de piridazinona | |
AR084011A1 (es) | Compuestos nitrogenados heterociclicos utiles para el tratamiento de infecciones por el virus sincitial respiratorio (rsv), proceso para prepararlos y composiciones farmaceuticas que los contienen | |
CO5640152A2 (es) | Composiciones farmaceuticas para inhibidores de la proteasa del virus de la hepatitis c | |
UY30603A1 (es) | Derivados de 2-aril-6-fenil-imidazo[1, 2-a]piridinas, su preparacion y su aplicacion en terapéutica | |
AR088226A1 (es) | Derivados piperidinicos heterociclicos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades neurodegenerativas | |
NI201000022A (es) | Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparación, su aplicación como medicamentos, composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met. | |
AR086538A1 (es) | COMPUESTOS PARA REDUCIR LA PRODUCCION DE b-AMILOIDE | |
CO6361930A2 (es) | Nuevas combinaciones de compuestos heterociclicos nitrogenados antibacterianos con otros compuestos antibacterianos y su utilizacion como medicamentos | |
UY30105A1 (es) | Derivados nuevos azufrados de urea cíclica, su preparación y su utilización farmacéutica como inhibidores de quinasas. | |
ECSP11011201A (es) | Combinaciones que comprenden metotrexato e inhibidores de dhodh | |
CY1111269T1 (el) | Ρυθμιστες βενζιμιδαζολης του vr1 | |
CU20090048A7 (es) | Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
AR066606A1 (es) | Compuestos de heteroarilamida pirimidona | |
AR070273A1 (es) | Derivados de heteroarilamida diazepinopirimidinona sustituidos utiles en el tratamiento y/o prevencion de enfermedades neurodegenerativas y otras, provocadas por la actividad anormal de quinasas gsk3beta, medicamentos que los contienen y proceso de preparacion e intermediarios. | |
UY30104A1 (es) | Derivados nuevos de urea ciclica, su preparacinn y su utilizacinn farmacéutica como inhibidores de cinasas | |
AR070274A1 (es) | Derivados arilamida diazepinopirimidona sustituidos utiles en el tratamiento y/o prevencion de enfermedades neurodegenerativas y otras, provocadas por la actividad anormal de quinasas gsk3beta, medicamentos que los contienen y proceso de preparacion e intermediarios. | |
CU20080165A7 (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
BR112015015275A2 (pt) | composto heterocíclico substituído por halogênio | |
AR066605A1 (es) | Derivados de heteroarilamida pirimidona | |
ES2606839T3 (es) | Tetraaza-ciclopenta[a]indenilo y su uso como moduladores alostéricos positivos | |
AR073043A1 (es) | Compuestos de azetidinas polisustituidos, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de los mismos en el tratamiento de enfermedades respiratorias, metabolicas y del sistema nervioso central, entre otras. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused | ||
FG | Application granted |